502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer

Authors

Z BakounyFollow
P Grover
C Labaki
J AwosikaFollow
S Gulati
C-Y Hsu
M A. BilenFollow
O Eton
L Fecher
C Hwang
H Khan
R R. McKay
E Ruiz
L Weissmann
Michael A. Thompson, Advocate Aurora HealthFollow
D Shah
J Warner
Y Shyr
T K. ChoueiriFollow
T Wise-Draper

Recommended Citation

Bakouny Z, Grover P, Labaki C, et al. 502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer. Annals of Oncology : Official Journal of the European Society for Medical Oncology. 2022 Sep;33(9):S772-S773. PMCID: PMC9472565.

Document Type

Abstract